Logo image of RBOT

VICARIOUS SURGICAL INC-A (RBOT) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:RBOT - US92561V2088 - Common Stock

2.46 USD
-0.12 (-4.65%)
Last: 11/21/2025, 8:04:00 PM
2.46 USD
0 (0%)
After Hours: 11/21/2025, 8:04:00 PM
Fundamental Rating

2

Overall RBOT gets a fundamental rating of 2 out of 10. We evaluated RBOT against 188 industry peers in the Health Care Equipment & Supplies industry. While RBOT has a great health rating, there are worries on its profitability. RBOT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RBOT had negative earnings in the past year.
RBOT had a negative operating cash flow in the past year.
RBOT had negative earnings in 4 of the past 5 years.
RBOT had a negative operating cash flow in each of the past 5 years.
RBOT Yearly Net Income VS EBIT VS OCF VS FCFRBOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

RBOT has a worse Return On Assets (-145.82%) than 85.11% of its industry peers.
Looking at the Return On Equity, with a value of -258.54%, RBOT is doing worse than 74.47% of the companies in the same industry.
Industry RankSector Rank
ROA -145.82%
ROE -258.54%
ROIC N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
RBOT Yearly ROA, ROE, ROICRBOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

RBOT's Gross Margin of 5.76% is on the low side compared to the rest of the industry. RBOT is outperformed by 83.51% of its industry peers.
The Profit Margin and Operating Margin are not available for RBOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RBOT Yearly Profit, Operating, Gross MarginsRBOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

More info and screens

7

2. Health

2.1 Basic Checks

RBOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBOT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RBOT has less shares outstanding
There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RBOT Yearly Shares OutstandingRBOT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RBOT Yearly Total Debt VS Total AssetsRBOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -11.00, we must say that RBOT is in the distress zone and has some risk of bankruptcy.
RBOT's Altman-Z score of -11.00 is on the low side compared to the rest of the industry. RBOT is outperformed by 78.72% of its industry peers.
There is no outstanding debt for RBOT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11
ROIC/WACCN/A
WACC8.7%
RBOT Yearly LT Debt VS Equity VS FCFRBOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

RBOT has a Current Ratio of 5.11. This indicates that RBOT is financially healthy and has no problem in meeting its short term obligations.
RBOT has a Current ratio of 5.11. This is in the better half of the industry: RBOT outperforms 79.26% of its industry peers.
A Quick Ratio of 5.11 indicates that RBOT has no problem at all paying its short term obligations.
RBOT has a better Quick ratio (5.11) than 83.51% of its industry peers.
Industry RankSector Rank
Current Ratio 5.11
Quick Ratio 5.11
RBOT Yearly Current Assets VS Current LiabilitesRBOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

RBOT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.05%, which is quite good.
RBOT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -36.51%.
EPS 1Y (TTM)12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.86%
Revenue 1Y (TTM)-36.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, RBOT will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.27% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y18.49%
EPS Next 2Y22.43%
EPS Next 3Y16.27%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RBOT Yearly Revenue VS EstimatesRBOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2027 2028 2029 2030 20M 40M 60M 80M 100M
RBOT Yearly EPS VS EstimatesRBOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RBOT. In the last year negative earnings were reported.
Also next year RBOT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBOT Price Earnings VS Forward Price EarningsRBOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RBOT Per share dataRBOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as RBOT's earnings are expected to grow with 16.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.43%
EPS Next 3Y16.27%

More info and screens

0

5. Dividend

5.1 Amount

RBOT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VICARIOUS SURGICAL INC-A

NYSE:RBOT (11/21/2025, 8:04:00 PM)

After market: 2.46 0 (0%)

2.46

-0.12 (-4.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-16 2026-03-16/amc
Inst Owners33.98%
Inst Owner Change-6.96%
Ins Owners2.58%
Ins Owner Change-0.03%
Market Cap16.11M
Revenue(TTM)13.85M
Net Income(TTM)-59.63M
Analysts77.78
Price Target9.18 (273.17%)
Short Float %3.9%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.82%
Min EPS beat(2)-2.78%
Max EPS beat(2)12.43%
EPS beat(4)2
Avg EPS beat(4)3.09%
Min EPS beat(4)-11.28%
Max EPS beat(4)13.99%
EPS beat(8)5
Avg EPS beat(8)12.72%
EPS beat(12)7
Avg EPS beat(12)7.44%
EPS beat(16)8
Avg EPS beat(16)5.15%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.99%
EPS NY rev (1m)4.3%
EPS NY rev (3m)4.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.74
P/FCF N/A
P/OCF N/A
P/B 0.7
P/tB 0.7
EV/EBITDA N/A
EPS(TTM)-9.05
EYN/A
EPS(NY)-5.44
Fwd EYN/A
FCF(TTM)-11.65
FCFYN/A
OCF(TTM)-11.64
OCFYN/A
SpS3.31
BVpS3.52
TBVpS3.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -145.82%
ROE -258.54%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.76%
FCFM N/A
ROA(3y)-49.66%
ROA(5y)-48.14%
ROE(3y)-67.76%
ROE(5y)-64.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.09%
Cap/Sales 0.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.11
Quick Ratio 5.11
Altman-Z -11
F-Score4
WACC8.7%
ROIC/WACCN/A
Cap/Depr(3y)193.53%
Cap/Depr(5y)211.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.86%
EPS Next Y18.49%
EPS Next 2Y22.43%
EPS Next 3Y16.27%
EPS Next 5YN/A
Revenue 1Y (TTM)-36.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year30.03%
EBIT Next 3Y13.79%
EBIT Next 5YN/A
FCF growth 1Y-11.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-15.67%
OCF growth 3YN/A
OCF growth 5YN/A

VICARIOUS SURGICAL INC-A / RBOT FAQ

What is the ChartMill fundamental rating of VICARIOUS SURGICAL INC-A (RBOT) stock?

ChartMill assigns a fundamental rating of 2 / 10 to RBOT.


What is the valuation status for RBOT stock?

ChartMill assigns a valuation rating of 0 / 10 to VICARIOUS SURGICAL INC-A (RBOT). This can be considered as Overvalued.


How profitable is VICARIOUS SURGICAL INC-A (RBOT) stock?

VICARIOUS SURGICAL INC-A (RBOT) has a profitability rating of 0 / 10.


What is the expected EPS growth for VICARIOUS SURGICAL INC-A (RBOT) stock?

The Earnings per Share (EPS) of VICARIOUS SURGICAL INC-A (RBOT) is expected to grow by 18.49% in the next year.